1 / 25

Health Data Information System II

Health Data Information System II. August, 31, 2018. Songrach Chaiyad , Com MT, Ph.D. Sankampheang Hospital Chiang Mai Provincial Public Health Office. Information part of the larger Health System. HIS has multiple meanings.

barrett
Télécharger la présentation

Health Data Information System II

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Health Data Information System II August, 31, 2018 SongrachChaiyad, Com MT, Ph.D. Sankampheang Hospital Chiang Mai Provincial Public Health Office

  2. Information part of the larger Health System

  3. HIS has multiple meanings • For the health managers, it means aggregate data; Health Management Information System (HMIS) • For the nurses and doctors, it means data related to patients; (electronic) medical records (EMR) • For the lab technicians, it means data related to blood samples and test results; laboratory information system • Similarly, for human resources, logistics, finance, etc • Thus, HIS is a much broader term which encompasses these various information systems Ref: Uio: Department of Informatics University of Oslo

  4. Ref: Uio: Department of Informatics University of Oslo

  5. Electronic Medical Records (EMR) • Are related to patient care, and focus on patient data (name, age, symptoms, medical history, test results etc), and is collected longitudinally over time • Functionality is around patient care, registration symptoms, test results, medicine prescription, referrals, billing, etc. Ref: Uio: Department of Informatics University of Oslo

  6. EMR: Supports patient workflow Ref: HispIndia

  7. System Flow of the Readmission Forecast by Using Big EMR Data https://www.itri.org.tw/eng/Content/MSGPic/contents.aspx?&SiteID=1&MmmID=617751562433643461&MSID=744304106227526127

  8. Towards Smart Health Information System forSmart Living and Better Care Services Ref: asanee.kawtrakul@nectec.or.th

  9. Review Literature A Comparison of HbA1C and Fasting Blood Sugar Tests in General Population Ref: Zahra Ghazanfari, Ali Akbar Haghdoost, Sakineh Mohammad Alizadeh, Jamileh Atapour, Farzaneh Zolala Int J Prev Med 2010; 1(3): 187-194

  10. Ref: Thai CV risk score

  11. Sample of laboratory parameters for CVD risk

  12. Thank you for your attention

  13. Development of reverse transcription (RT)-PCR assay and polyacrylamide gel electrophoresis for rapid detectionofnucleophosmingene mutations in acute myelogenous leukemia. BY: RattanaKongta 611135902 Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University

  14. Objectives To develop and validate the utility of reverse transcription (RT)-PCR assay and polyacrylamide gel electrophoresis for detection of NPM1 mutations that allows specific, inexpensive and simple detecting for NPM1 mutations. 1 2 Detecting for NPM1 mutations in acute myelogenous leukemia patients.

  15. Researcher Researcher Researcher Researcher Researcher Acute myelogenous leukemia (AML) Frequencies of alterations in AML Molecular methods for detecting NPM1 mutations Nucleophosmin(NPM1) gene Reverse transcription (RT)-PCR assay Polyacrylamide gel electrophoresis

  16. Incidence of NPM1 mutation inThailand Patient behavior Medical history Gender Hospital information Diagnosis Incidence of NPM1 mutation in Chiang Mai Detection of NPM1 mutation in AML patient samples WBC parameters

  17. THANK YOU For your attention

  18. 18 Optimization of anti-CD3 monoclonal antibody coated paramagnetic beads for T cell activation PassawornCheyasawan 611135903 Advisor Dr. WitidaLaopajon

  19. 19 In-house anti-CD3 mAb coated beads Paramagnetic beads Anti-CD3mAb (OKT3) Passive adsorption Anti-CD3mAb coated beads

  20. 20 Activate PBMC by OKT3 coated paramagnetic beads PBMC = 1x106 cells Media = 10% FCS RPMI 1640 OKT3 coated paramagnetic beads Tissue culture plate Incubate 18 hrs. Detect CD69 expression in CD3 positive cell by flow cytometry Activated surface marker

  21. Health information data • Tool for studying T lymphocytes functions • Compare In-house beads vs commercial beads for activated T lymphocytes • Save cost • Publish for shared information

  22. Preparation of anti-H (lectin) from the crude extract of 5 plants Wongsakan Chuathong 611135904

  23. ตารางที่ 1. เปรียบเทียบผลของการเตรียม anti-H (lectin) จากเมล็ดมะระจีน เยื่อมะระและเมล็ดถั่วพู *อ้างอิงมาจากภาคนิพนธ์ (2559) ของนายภานุภัส นาดี

  24. Rarity of Bombay Phenotype Among Blood Donors in Sokoto North Western, Nigeria Wide Variety of Point Mutations in the H Gene of Bombay and Para-Bombay Individuals That Inactivate H Enzyme

  25. for your kind attention

More Related